Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.410 -0.240 (-14.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Why PacBio (PACB) Shares Are Getting Obliterated Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 14.2% in the afternoon session after the company reported mixe... 
Via StockStory
Topics Earnings Economy
News headline image
PacBio (PACB) Q1 2026 Earnings Call Transcript ↗
PacBio (PACB) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness
Genomics company Pacific Biosciences of California (NASDAQ:PACB) fell short of the market’s revenue expectations in Q1 CY2026, with sales flat year on year a... 
Via StockStory
PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) Beats Q4 2025 Revenue and EPS Estimates ↗
Via Chartmill
News headline image
Pacific Biosciences of California Q1 Earnings Call Highlights ↗
Pacific Biosciences of California (NASDAQ:PACB) reported first-quarter 2026 revenue of $37.2 million, roughly flat year over year, as record consumables revenue offset weaker-than-expected instrument... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
3 Small-Cap Stocks We Find Risky
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
Topics Artificial Intelligence
News headline image
PacBio (NASDAQ:PACB) Misses Q1 CY2026 Sales Expectations
Genomics company Pacific Biosciences of California (NASDAQ:PACB) fell short of the market’s revenue expectations in Q1 CY2026, with sales flat year on year a... 
Via StockStory
Topics Artificial Intelligence
News headline image
PacBio (PACB) Q1 Earnings Report Preview: What To Look For
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting earnings this Thursday after market hours. Here’s what investors should kn... 
Via StockStory
News headline image
1 Cash-Burning Stock with Solid Fundamentals and 2 We Turn Down
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them... 
Via StockStory
News headline image
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ... 
Via StockStory
Topics Economy
News headline image
Ontario-Based DNAstack Leads Sovereign AI for Genomics and Health with Goal of Making Canadians Healthier and Reducing Strain on our Healthcare System
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Economy Government Stocks
News headline image
3 Small-Cap Stocks with Warning Signs
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
Topics Artificial Intelligence
News headline image
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and it... 
Via StockStory
Topics Artificial Intelligence
News headline image
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ... 
Via StockStory
Topics Economy Stocks
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
Topics Economy
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
News headline image
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Unprofitable Stocks We Approach with Caution
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key... 
Via StockStory
Topics Economy Government Stocks
News headline image
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026
WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the... 
Via MarketMinute
Topics Earnings Economy World Trade
News headline image
Why Is PacBio (PACB) Stock Soaring Today
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 6.3% in the afternoon session after the company announced a collaboration with DNAstack to launch the world's first... 
Via StockStory
Topics Government Supply Chain World Trade
News headline image
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Economy Government World Trade
News headline image
PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings?
PacBio’s 31.3% return over the past six months has outpaced the S&P 500 by 23.8%, and its stock price has climbed to $1.67 per share. This was partly thanks to its solid quarterly results, and the... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
5 Must-Read Analyst Questions From PacBio’s Q4 Earnings Call
Pacific Biosciences’ fourth quarter results exceeded Wall Street’s expectations, supported by record consumables revenue and robust instrument placements, particularly for the Revio and Vega sequencing... 
Via StockStory
Topics Earnings
News headline image
1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.8% year on year to $44.65 million. Its non-GAAP... 
Via StockStory
News headline image
PacBio (PACB) Q4 2025 Earnings Call Transcript ↗
PacBio (PACB) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.8% year on year to $44.65 million. Its non-GAAP... 
Via StockStory
News headline image
PacBio Earnings: What To Look For From PACB
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.